Cargando…

Exploring HIV-Associated Neurocognitive Impairment in the Era of Effective Antiretroviral Therapy: A Primary Healthcare Perspective

The prevalence of HIV-associated neurocognitive impairment (H-NCI) is concerning. Individuals on effective antiretroviral therapy (ART) may still be at risk for H-NCI as they experience longer life expectancies. There are, however, few professionals with knowledge and skills to identify H-NCI, in lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munsami, Adele, Nightingale, Sam, Sorsdahl, Katherine, Joska, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411698/ https://www.ncbi.nlm.nih.gov/pubmed/35770984 http://dx.doi.org/10.1177/10497323221110801

Ejemplares similares

Integrating HIV-Associated Neurocognitive Impairment Screening within Primary Healthcare Facilities: A Pilot Training Intervention
por: Munsami, Adele, et al.
Publicado: (2022)

Screening for HIV-Associated Neurocognitive Impairment: Relevance of Psychological Factors and Era of Commencement of Antiretroviral Therapy
por: Herrmann, Susan, et al.
Publicado: (2019)

Peripheral blood lymphocyte proviral DNA predicts neurocognitive impairment in clade C HIV
por: Ruhanya, Vurayai, et al.
Publicado: (2020)

Antiretroviral therapy improves neurocognitive impairment in people living with HIV? A meta-analysis
por: Gao, Chang, et al.
Publicado: (2020)

Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium
por: Decloedt, Eric H., et al.
Publicado: (2016)

Young South African Women on Antiretroviral Therapy Perceptions of a Psychological Counselling Program to Reduce Heavy Drinking and Depression
por: Petersen Williams, Petal, et al.
Publicado: (2020)

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
por: Heaton, Robert K., et al.
Publicado: (2010)

Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy
por: Winston, Alan, et al.
Publicado: (2013)

Neurocognitive and functional impairment in adult and paediatric tuberculous meningitis
por: Davis, Angharad G., et al.
Publicado: (2019)

NEUROCOGNITIVE IMPAIRMENTS IN HIV INFECTION
por: Edwin, Tony, et al.
Publicado: (1999)

Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia
por: Wubetu, Abate Dargie, et al.
Publicado: (2021)

Palliative care for HIV in the era of antiretroviral therapy availability: perspectives of nurses in Lesotho
por: Kell, Megan E, et al.
Publicado: (2009)

A Mobile App to Screen for Neurocognitive Impairment: Preliminary Validation of NeuroScreen Among HIV-Infected South African Adults
por: Robbins, Reuben N, et al.
Publicado: (2018)

Exploring Substance Use and HIV Treatment Factors Associated with Neurocognitive Impairment among People Living with HIV/AIDS
por: Attonito, Jennifer M., et al.
Publicado: (2014)

Predicting Efavirenz Concentrations in the Brain Tissue of HIV‐Infected Individuals and Exploring their Relationship to Neurocognitive Impairment
por: Srinivas, Nithya, et al.
Publicado: (2019)

HIV Cerebrospinal Fluid Escape and Neurocognitive Pathology in the Era of Combined Antiretroviral Therapy: What Lies Beneath the Tip of the Iceberg in Sub-Saharan Africa?
por: Collier, Dami Aderonke, et al.
Publicado: (2018)

344. HIV and Diabetes in the Era of Antiretroviral Therapy
por: Sabbaj. Spieler, Gabriel, et al.
Publicado: (2019)

Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy
por: Pérez-Valero, Ignacio, et al.
Publicado: (2013)

Aging, neurocognitive impairment and adherence to antiretroviral therapy in human immunodeficiency virus-infected individuals
por: Pinheiro, Cezar Arthur Tavares, et al.
Publicado: (2016)

Impact of antiretroviral therapy intensification with C-C motif chemokine receptor 5 antagonist maraviroc on HIV-associated neurocognitive impairment
por: Shikuma, Cecilia M., et al.
Publicado: (2023)

Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial
por: Thela, Lindokuhle, et al.
Publicado: (2023)

Interdiscliplinary Perspectives on Aging at Home Alone With Neurocognitive Impairment
por: Girling, Laura, et al.
Publicado: (2020)

HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression?
por: Bandera, Alessandra, et al.
Publicado: (2019)

Depression and diagnosis of neurocognitive impairment in HIV-positive patients
por: Pinheiro, C.A.T., et al.
Publicado: (2016)

Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia
por: O’Bryan, Thomas A., et al.
Publicado: (2015)

Primary or secondary prevention of HIV-associated histoplasmosis during the early antiretrovirals for all era
por: Nacher, Mathieu, et al.
Publicado: (2023)

Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study
por: Lawler, Kathy, et al.
Publicado: (2010)

Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand
por: Aurpibul, Linda, et al.
Publicado: (2022)

Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe
por: Nyamayaro, Primrose, et al.
Publicado: (2020)

HIV-Associated Neurocognitive Disorders: A Global Perspective
por: Saloner, Rowan, et al.
Publicado: (2017)

The Influence of HLA on HIV-Associated Neurocognitive Impairment in Anhui, China
por: Schrier, Rachel D., et al.
Publicado: (2012)

Computerized screening tools for neurocognitive impairment in patients with HIV infection
por: Cercel, Ioana-Catrinel, et al.
Publicado: (2014)

Prevalence and Predictors of Neurocognitive Impairment in Ethiopian Population Living with HIV
por: Salahuddin, Mohammed, et al.
Publicado: (2020)

Microalbuminuria: a sentinel of neurocognitive impairment in HIV-infected individuals?
por: Moulignier, Antoine, et al.
Publicado: (2020)

Factors associated to neurocognitive impairment in older adults living with HIV
por: Gutierrez-San-Juan, Júlia, et al.
Publicado: (2022)

Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy
por: Bangirana, Paul, et al.
Publicado: (2017)

Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital
por: Mugendi, A. G., et al.
Publicado: (2019)

MR spectroscopy in HIV associated neurocognitive disorder in the era of cART: a review
por: Chaganti, Joga, et al.
Publicado: (2021)

HIV-associated wasting prevalence in the era of modern antiretroviral therapy
por: Siddiqui, Javeed, et al.
Publicado: (2022)

HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy
por: Castelli, Roberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qh25eaecemc1leki8l6491jcgq